ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Oklahoma » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in Oklahoma

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
VIVEK KHETPAL M.D.

Cardiovascular Disease

28,996

$1.85M

1261
809 are 65+

7%
patients receiving schedule two controlled substances

Avg: 0%

33%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 26%

$64
Average prescription price

Avg: $63

BRUCE DANIELS MD

Cardiovascular Disease

13,740

$896K

575
489 are 65+

8%
patients receiving schedule two controlled substances

Avg: 0%

21%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 26%

$65
Average prescription price

Avg: $63

UMA GUNIGANTI MD

Cardiovascular Disease

13,333

$635K

1043
948 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $63

YEESE ONG M.D.

Cardiovascular Disease

12,645

$952K

684
541 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 26%

$75
Average prescription price

Avg: $63

JOHN WILLIAMS M.D.

Cardiovascular Disease

11,801

$789K

1075
961 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 26%

$67
Average prescription price

Avg: $63

STANLEY DEFEHR MD

Cardiovascular Disease

11,327

$758K

1106
1009 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 26%

$67
Average prescription price

Avg: $63

PHILIP ADAMSON M.D.

Cardiovascular Disease

10,542

$850K

578
469 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 26%

$81
Average prescription price

Avg: $63

SYED ABBAS M.D.

Cardiovascular Disease

10,038

$469K

556
446 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 26%

$47
Average prescription price

Avg: $63

RALPH ENSLEY M.D.

Cardiovascular Disease

9,189

$556K

657
583 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 26%

$61
Average prescription price

Avg: $63

CARL RUBENSTEIN M.D.

Cardiovascular Disease

8,936

$1.12M

590
542 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 26%

$126
Average prescription price

Avg: $63

RONALD WHITE M.D.

Cardiovascular Disease

8,830

$569K

693
658 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 26%

$64
Average prescription price

Avg: $63

SURESH CHANDRASEKARAN MD

Cardiovascular Disease

8,804

$527K

587
431 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $63

BRYAN PERRY M.D.

Cardiovascular Disease

8,617

$780K

749
642 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 26%

$91
Average prescription price

Avg: $63

TODD LINDLEY M.D.

Cardiovascular Disease

8,356

$626K

795
697 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 26%

$75
Average prescription price

Avg: $63

RUBEN SUNGA M.D.

Cardiovascular Disease

7,981

$232K

526
402 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 26%

$29
Average prescription price

Avg: $63

WILLIAM TINKER M.D.

Cardiovascular Disease

7,437

$559K

705
623 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 26%

$75
Average prescription price

Avg: $63

JEFFREY ASBURY MD

Cardiovascular Disease

7,389

$560K

435
366 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 26%

$76
Average prescription price

Avg: $63

SUDHIR GUPTA M.D. F.A.C.C.

Cardiovascular Disease

7,216

$361K

551
452 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 26%

$50
Average prescription price

Avg: $63

ARIF SHAKIR MD

Cardiovascular Disease

7,034

$407K

468
371 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 26%

$58
Average prescription price

Avg: $63

RONALD SUTOR MD

Cardiovascular Disease

7,028

$401K

472
417 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 26%

$57
Average prescription price

Avg: $63

JANE BARE M.D.

Cardiovascular Disease

6,793

$385K

585
505 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 26%

$57
Average prescription price

Avg: $63

GARY DYKSTRA D.O.

Cardiovascular Disease

6,585

$440K

755
654 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 26%

$67
Average prescription price

Avg: $63

RONALD HOPE M.D.

Cardiovascular Disease

6,585

$541K

480
419 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 26%

$82
Average prescription price

Avg: $63

MICHAEL SELLERS MD

Cardiovascular Disease

6,410

$321K

435
400 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 26%

$50
Average prescription price

Avg: $63

ROBERT SWEENEY MD

Cardiovascular Disease

6,362

$534K

535
451 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 26%

$84
Average prescription price

Avg: $63

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank